rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
UNIPROT |
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
|
24893135 |
2014 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
UNIPROT |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
UNIPROT |
Clinical utility gene card for: multiple endocrine neoplasia type 2.
|
21863057 |
2012 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
BEFREE |
MEN2A (C618S), MEN2A/familial MTC (FMTC) (C620S), and MEN2B (M918T).
|
22199277 |
2011 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
UNIPROT |
Medullary thyroid cancer: management guidelines of the American Thyroid Association.
|
19469690 |
2009 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
UNIPROT |
Guidelines for diagnosis and therapy of MEN type 1 and type 2.
|
11739416 |
2001 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
UNIPROT |
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
|
8918855 |
1996 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
BEFREE |
Two mutations (C609Y and C620R) we identified have previously been associated with multiple endocrine neoplasia type 2A (MEN2A), medullary thyroid carcinoma (MTC) and, on rare occasions, HSCR.
|
7633441 |
1995 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
|
0.830 |
GeneticVariation
|
BEFREE |
We have identified a mutation in codon 620, 2053 T-->C (Cys620Arg), and two mutations in codon 634 of exon 11 of RET, 2095 T-->C (Cys634Arg) and 2096 G-->A (Cys634Tyr), all three of which were present in both MEN2A and FMTC families.
|
7835899 |
1994 |
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
G |
0.830 |
CausalMutation
|
CLINVAR |
|
|
|
rs77316810
|
|
Multiple Endocrine Neoplasia Type 2a
|
C |
0.830 |
CausalMutation
|
CLINVAR |
|
|
|